This argumentative essay examines whether public health funding should be directed toward complementary medicine — therapies and herbal treatments used alongside or instead of conventional medicine. The paper defines complementary and alternative medicine, distinguishes between systematic and unsystematic practitioners, and surveys the ethical tensions surrounding efficacy, patient safety, and informed consent. Drawing on clinical studies involving Chinese medicine, homeopathy, and herbal supplements, the essay evaluates research evidence while acknowledging gaps in standardized testing. It also considers legal barriers facing unregistered practitioners and the liability risks governments assume when funding unproven treatments, ultimately concluding that complementary medicine must build systematic credibility before public funding is appropriate.
The paper demonstrates argument from evidence with qualification: rather than making an absolute claim, it acknowledges that some complementary treatments show measurable results (citing peer-reviewed BMC studies) while maintaining that lack of standardization and legal accountability justifies withholding public funds until stricter protocols are established. This concession-and-rebuttal structure strengthens the overall position.
The essay opens with definitional groundwork — distinguishing complementary from alternative medicine and mapping the field's breadth. The central section introduces bioethical principles (autonomy, beneficence) and evaluates research evidence. A third section addresses legal frameworks for registered and unregistered practitioners and the liability risks of government endorsement. A brief concluding section recommends alternative funding pathways such as grants and third-party billing, tying the argument together without overstating its conclusions.
Complementary medicine describes the use of therapies and herbal medicines not commonly practiced by conventional doctors. The term itself refers to receiving standard medical treatment from a physician while simultaneously using such therapies, so that both treatments work together to improve the patient's health. Many of these therapies and herbal medicines have long been a part of everyday life, yet most people do not realize they fall under the umbrella term of complementary medicine.
A closely related concept is alternative medicine. Alternative medicine refers to the use of herbal medicines or therapies instead of conventional medicine, rather than alongside it. With the increasing preference for complementary approaches and growing patient demand, the term "alternative medicine" is gradually being replaced (Whorton, 1998). Many people have begun choosing complementary medicine for their health problems in place of treatments recommended by conventional medical practitioners.
Complementary medicine has shown results in addressing many health problems, yet its use is widely considered ethically contentious. Critics point out that the efficacy of complementary medicine is uncertain because rigorous proof is often lacking. Most techniques and therapies have not been tested on appropriate samples before being distributed to the public. There is no systematic recording of active ingredients, and most herbal medicines are not legally registered for distribution. Nevertheless, the number of patients using these products continues to grow, making regulation of this market an increasingly urgent global challenge (Alameddine, 2011). Physicians have grown concerned about patient safety, fearing that the easy availability of these appealing but inadequately tested options may harm patients who use them without professional consultation.
The field of complementary medicine is extremely broad: anything not legally classified as mainstream medicine may be considered part of it, encompassing numerous therapies, ointments, and capsules. This breadth can make the field seem unmanageable; however, it is further divided into two categories — systematic and unsystematic professions. The systematic category includes chiropractors, who are legally registered, have declared specializations, and are accountable for their practice. Their credibility rests on the transparency of their work (Whorton, 1998).
The unsystematic category, by contrast, includes practices such as aromatherapy, which carry no legal declaration and no proof of specialization, as they fall outside the formally recognized medical field (Whorton, 1998). Herbal and homeopathic medicines are commonly available in pharmacies, yet pharmacists often have little information about them. If questioned about efficacy, they may be unable to accurately state what these natural medicines contain or in what quantities (Kwan, 2008).
Despite the controversies surrounding complementary medicine, its use is predicted to increase over time, even given the ethical concerns attached to it. This growth raises important health and safety questions for regulators around the world (Clement, 2005).
Public health funding of medicines is a critically important issue because every citizen has healthcare needs. With the global rise in disease and declining immunity, nearly everyone requires healthcare services at some point in their lives. Public health funding means pooling resources to meet as many of these needs as possible, ideally at no direct cost to the patient. Accountability for such funds is maintained through public health financing mechanisms managed by either the state or not-for-profit organizations. One prominent example is the American Public Health Association, which actively works to meet the healthcare needs of American citizens. Even with such organizations operating in large numbers, available funds remain insufficient relative to demand. The number of diseases and health conditions is rising rapidly, new research into treatments requires adequate funding, and a large percentage of people cannot afford prescribed medicines — all of which underscores the need for accessible, high-quality healthcare services.
Directing public health funding toward complementary medicine is a demand growing in many countries, but because of clear ethical concerns about untested efficacy, governments have generally declined to authorize such funding. A 1993 survey found that one in three Americans used complementary medicine — a user base so large that proponents argue public health funds must be allocated accordingly (Whorton, 1998).
Several factors explain why public funding for complementary medicines is withheld. Chief among them is the absence of tested or documented efficacy. These medicines have not been developed through systematic processes that would analyze effectiveness, identify side effects, or establish accurate dosages. They frequently lack complete information for the consumer, which is an ongoing health and safety concern.
Additionally, existing public funds are already strained by the need to address infectious diseases, fund vaccination programs, and respond to non-disease emergencies such as earthquakes, hurricanes, radioactive exposure, and explosions. These situations demand prompt, medically precise intervention, leaving little margin for unverified treatments. Diverting funds to medicines whose efficacy cannot be accurately defined would therefore carry considerable risk.
A study conducted in Taiwan examined the use of Chinese medicines, which are among the most popular complementary treatments worldwide. In Chinese and East Asian societies, traditional Chinese medicine plays an active role in modern healthcare and is even covered under Taiwan's National Health Insurance Program. The study found that many patients with liver cancer used Chinese medicines regularly, though — notably — these medicines were not covered by national insurance, whereas conventional medicine was (Liao et al., 2012). The researchers concluded that health policy-makers should recognize the significant extent to which patients use Chinese medicines, even while questions about efficacy remain central to any funding debate.
A second study enrolled 78 men aged 25 to 50 years with mild to moderate erectile dysfunction to evaluate a multi-herb supplement. Using a randomized, double-blind, placebo-controlled methodology, the study demonstrated that the herbal supplement VigRX Plus was well tolerated and significantly more effective than the placebo in improving sexual function (Shah et al., 2012). This finding illustrates that complementary medicines are not necessarily without merit; some can demonstrate measurable results. However, the unsystematic production processes for most such medicines continue to prevent their legal funding.
The funding support for complementary therapies such as Myotherapy should not be government-based, but should instead be funded through donations, grants, or third-party billing. Credibility in this field must be earned by establishing clearer and more systematic production and testing processes, and by defining efficacy as accurately as possible. Greater transparency and accountability would, in turn, give funding bodies more confidence in supporting complementary medicine for the public's benefit.
Alameddine, M., Naja, F., Abdel-Salam, S., Maalouf, S., & Matta, C. (2011, August 28). Stakeholders' perspectives on the regulation and integration of complementary and alternative medicine products in Lebanon: A qualitative study. BMC Complementary and Alternative Medicine, 11(71). doi:10.1186/1472-6882-11-71
Clement, Y. N., Williams, A. F., Khan, K., Bernard, T., Bhola, S., Fortune, M., Medupe, O., Nagee, K., & Seaforth, C. E. (2005, November 18). A gap between acceptance and knowledge of herbal remedies by physicians: The need for educational intervention. BMC Complementary and Alternative Medicine, 5(20). doi:10.1186/1472-6882-5-20
Kwan, D., Boon, H. S., Hirschkorn, K., Welsh, S., Jurgens, T., Eccott, L., Heschuk, S., Griener, G. G., & Cohen-Kohler, J. C. (2008, July 14). Exploring consumer and pharmacist views on the professional role of the pharmacist with respect to natural health products: A study of focus groups. BMC Complementary and Alternative Medicine, 8(40). doi:10.1186/1472-6882-8-40
Rhodes, P. J., Small, N., Ismail, H., & Wright, J. P. (2008, March 20). The use of biomedicine, complementary and alternative medicine, and ethnomedicine for the treatment of epilepsy among people of South Asian origin in the UK. BMC Complementary and Alternative Medicine, 8(7). doi:10.1186/1472-6882-8-7
Shah, G. R., Chaudhari, M. V., Patankar, S. B., Pensalwar, S. V., Sabale, V. P., & Sonawane, N. A. (2012, September 15). Evaluation of a multi-herb supplement for erectile dysfunction: A randomized double-blind, placebo-controlled study. BMC Complementary and Alternative Medicine, 12(155). doi:10.1186/1472-6882-12-155
Stub, T., Musial, F., & Alraek, T. (2012, June 12). Adverse effects of homeopathy, what do we know? A systematic review. BMC Complementary and Alternative Medicine, 12(Suppl 1), P287. doi:10.1186/1472-6882-12-S1-P287
Weir, M. (2005, April 1). Complementary and alternative medicine — Legal issues. The National Legal Eagle, 11(1), Art. 4. Retrieved from
Whorton, J., PhD (Instructor), Medical History and Ethics. (1998). [University course materials].
Always verify citation format against your institution’s current style guide requirements.